Mirum Pharmaceuticals (MIRM) Short-term Investments (2019 - 2026)

Mirum Pharmaceuticals' Short-term Investments history runs 8 years deep, the most recent figure standing at $61.4 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 6.83% year-over-year to $61.4 million; the TTM figure through Mar 2026 stood at $61.4 million (down 6.83% YoY), while the FY2025 annual figure was $86.6 million, up 49.87% from the prior year.
• Short-term Investments for Q1 2026 stood at $61.4 million, down from $86.6 million in the prior quarter.
• The five-year high for Short-term Investments was $149.6 million in Q3 2022, with the low at $3.0 million in Q3 2023.
• The 5-year median for Short-term Investments is $69.7 million (2022), against an average of $73.5 million.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments sank 98.01% in 2023, then soared 1969.2% in 2024.
• Mirum Pharmaceuticals' Short-term Investments stood at $123.7 million in 2022, then sank by 97.6% to $3.0 million in 2023, then jumped by 1845.88% to $57.8 million in 2024, then soared by 49.87% to $86.6 million in 2025, then dropped by 29.19% to $61.4 million in 2026.
• Business Quant data shows MIRM's Short-term Investments at $61.4 million in Q1 2026, $86.6 million in Q4 2025, and $93.5 million in Q3 2025.